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Abstract: Composite bone cements were formulated with bioactive glass (MgOOSiO2O3CaO !
P2O5) as the filler and hydrophilic matrix. The matrix was composed of a starch/cellulose acetate
blend (SCA) as the solid component and a mixture of methylmethacrylate/acrylic acid (MMA/AA)
as the liquid component. The curing parameters, mechanical properties, and bioactive behavior of
these composite cements were determined. The addition of up to 30 wt % of glass improved both
compressive modulus and yield strength and kept the maximum curing temperature at the same
value presented by a typical acrylic-based commercial formulation. The lack of a strongly bonded
interface (because no coupling agent was used) had important effects on the swelling and mechan-
ical properties of the novel bone cements. However, bone cements containing AA did not show a
bioactive behavior, because of the deleterious effect of this monomer on the calcium phosphate
precipitation on the polymeric surfaces. Formulations without AA were prepared with MMA or
2-hydroxyethyl methacrylate (HEMA) as the liquid component. Only these formulations could
form an apatite-like layer on their surface. These systems, therefore, are very promising: They are
bioactive, hydrophilic, partially degradable, and present interesting mechanical properties. This
combination of properties could facilitate the release of bioactive agents from the cement, allow
bone ingrowth in the cement, and induce a press-fitting effect, improving the interfaces with both
the prosthesis and the bone. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 70B:
368–377, 2004
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INTRODUCTION
Conventional acrylic bone cements, despite the long-term re-
search aimed to improve their properties, still present several
problems. These include1–3 thermal necrosis of bone due to the
high exothermic temperature of the cement polymerization,
chemical necrosis of bone due to the release of unreacted MMA,
shrinkage during polymerization, weakness of the cement (and
the interfaces) when compared with the prosthesis and the bone,
and stress shielding of the bone due to improper transfer of load.
Many alternatives were developed to overcome these problems,
such as the incorporation of bioactive fillers to improve the
mechanical properties and increase the adhesion to bone,4 the
development of novel formulations with higher ductility and
lower tensile modulus to produce a more even stress distribution
between the prosthesis and the bone,5 and the use of adhesive
additives to increase adhesion between bone and the metal
prosthesis and minimize the gap between the interfaces,6 the
modification of the liquid phase in order to decrease the thermal
and chemical damage to tissue,7 and the development of two-
solution bone cements.8
Hydrophilic bone cements (HBCs) are another recent al-
ternative.1,9 They contain a hydrogel-forming monomer (AA,
HEMA) in the liquid component of the typical bone- cement
formulation, partially substituted for MMA in order to adjust
the mechanical and the swelling properties of the system.
Therefore, the key characteristics of the hydrophobic acrylic
cements, such as fast polymerization rate, injectability, and
high mechanical properties, are maintained; and the advan-
tages of hydrogels—good compatibility with body fluids and
tissues, improved release behavior of drugs, easier bioactiv-
ity10 and others—are added.
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These hydrophilic bone cements also incorporate a starch-
based blend that can degrade in the body and has already been
studied for a range of biomedical applications such as scaf-
folds for tissue engineering,11 systems for drug delivery,12
and proposed bone replacement and regeneration applica-
tions.13 Previous reports have shown that the swelling kinet-
ics of HBCs depends on the pH of the surrounding medium,9
that the amount of residual monomer is very low ("1 mol
%),14 and that the molar ratio of monomers used determined
the swelling kinetics and extent.15 They could become bio-
active by the addition of bioactive fillers such as HA, as
previously shown.14
This work reports on the development of composites of
starch-based bone cements with a new kind of bioactive glass
of the 3CaO ! P2O5OSiO2OMgO system, which has already
been used to induce the formation of a calcium phosphate
layer on its surface.16 The aims of the incorporation of the
glass were to improve the mechanical (compression) proper-
ties of the cements and to induce bioactivity on the system,
while keeping (or improving) the curing parameters. These
composites were characterized in terms of mechanical, cur-
ing, and swelling parameters. Their behavior under immer-
sion in simulated body fluid (SBF) was also investigated.
MATERIALS AND METHODS
Preparation of Bone Cements
Specimens were prepared by adding the solid component to
the liquid component. The solid was constituted by a com-
mercial cornstarch/cellulose acetate 50/50 wt % blend (SCA),
obtained from Novamont (Novara, Italy) and a bioactive
glass (BG) composed of 30.0% SiO2, 52.75% 3CaO ! P2O5
and 17.25% MgO (weight percentages). The glass had parti-
cle sizes of 1.2–60 !m, and the polymer particles were
smaller than 125 !m. The liquid was constituted by acrylic
acid (AA) and methylmethacrylate (MMA), which were used
as received. Benzoyl peroxide powder (BPO) was used as the
polymerization initiator at a molar concentration of 0.01 with
respect to the monomer amount. BPO was purified by frac-
tional recrystallization from ethanol and subsequently vac-
uum dried (m.p. 104°C). N-dimethylaminobenzyl alcohol
(DMOH) was used as the activator of the initiator, at a molar
concentration of 0.67 with respect to the BPO amount.
DMOH was synthesized following a previously described
procedure.17 The solid/liquid ratio employed was 60/40, the
MMA/AA molar ratio was 2/1, and the concentration of BG
was varied from 0 to 30 wt % (of the total mass). These
formulations were named as B0 (0% BG), B1 (10% BG), B2
(20% BG), and B3 (30% BG).
Other materials were used in this study to prepare addi-
tional formulations for bioactivity tests: nonsintered hydroxy-
apatite (HA, Plasma Biotal, United Kingdom), a commercial
bioactive glass (Bioglass" 45S5, U.S. Biomaterials Corp.),
and 2-hydroxyethyl-methacrylate (HEMA). The formulations
prepared with these materials are shown in Table I, together
with their respective compositions. HA had particle sizes of
4.1–9.0 !m, whereas Bioglass" exhibited a granulometric
distribution between 38 and 53 !m. The particle sizes of HA
and the glasses were determined by laser scattering analysis
with the use of a model Coulter LS100 particle size analyzer.
The preparation of specimens for subsequent tests was
carried out following the traditional method. The activator
DMOH was dissolved in the liquid phase. Initiator of free-
radical polymerization reaction was added to the solid phase.
Both phases were mixed and stirred by hand until the mixture
became paste-like with a high viscosity; the mass was then
placed into a poly(tetrafluoroethylene) (PTFE) mold to allow
it to cure. After 60 min, one group of specimens was removed
from the mold and put into an oven at 60°C until the group
attained constant weight. Another group was stored at 23°C
and 55% humidity.
Injection-molded discs of SCA, which were subjected to a
wet chemical surface modification with HNO3 and KMnO4,
were also used for bioactivity tests. These discs have previ-
ously been reported as able to induce an apatite-like layer on
their surfaces after 7 days of immersion in SBF.18
A commercially available, acrylic-based bone cement
(Palacos" R, Schering Plough, Belgium) was prepared by
following the manufacturer!s instructions. This was used as a
control for comparative purposes.
Curing Parameters
Dough time (td), setting time (ts), and maximum polymeriza-
tion temperature (Tmax) were measured with the use of a
PTFE mold (diameter of 40 mm), and a thermocouple con-
nected to a digital thermometer with a precision of #1°C.
The apparatus was placed inside an oven kept at 37 # 1°C.
The powder and liquid components of bone cements (stored
at 4°C) were mixed and packed into the PTFE mold when the
mixture reached the dough state; the mold was closed with a
plate containing a small passage in the center for the thermo-
couple. The thermocouple was located in the center of the
curing mass. Setting time was considered as the time at which
the temperature of the mass was the sum of the test temper-
ature (37°C) and maximum temperature (Tmax) divided by
two. This procedure was based on the ISO and ASTM stan-
dards for bone cements,19,20 with some modifications to bet-
ter simulate the temperatures used during clinical practice.
TABLE I. Formulations Prepared for Bioactivity Tests
Formulation Solid Componenta Liquid Component
A BG MMA $ AAb
C BG MMA
D SCA $ HAc MMA $ AAb
E SCA $ Bioglassc MMA $ AAb
F SCA $ BGc HEMA
G SCA HEMA
H SCA $ Bioglassc HEMA
a Solid/liquid ratio was 60/40 in all formulations.
b Molar ratio MMA/AA was 2/1.
c SCA/filler ratio was 1/1.
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Mechanical Properties
Tensile and compressive tests were carried out at room tem-
perature on an Instron 4505 Universal Mechanical Testing
Machine with the use of a load cell of 50 kN. A minimum of
five specimens was tested for each type of solicitation and
each sample. The specimens were tested either after storage
at 23°C and 55% humidity or after 7 days of immersion in an
isotonic saline solution (ISS: 0.154M NaCl aqueous solution
at pH 7.4) maintained at 37°C. In this case, they were tested
immediately after being removed from the solution.
For tensile characterization, cross-head speeds of 5 mm/
min were employed. The average size of rectangular speci-
mens for tensile tests was 3 % 5 % 30 mm. Specimens for the
compressive test were cylinders with 6-mm diameter and
12-mm height. The cross-head speed was 20 mm/min. Tests
were carried out up to failure or until 60% reduction in
specimen height.
Hydration Degree and Degradation Behavior
The water-uptake and the degradation of the prepared bone-
cement formulations were studied over a period of 100 days.
Cylindrical specimens were conditioned to constant weight in
an oven at 60°C, before being immersed in ISS [15-mL
solution per unit mass (g) of specimen]. The specimens were
removed at intervals of 3, 7, 14, 30, 60, and 100 days, rinsed
with distilled water, blotted on filter paper to remove surface
solution/water, and immediately weighed. They were then
dried in the oven at 60°C to a constant weight in order to
determine the weight loss. Water uptake (WU) and weight
loss (WL) were calculated as follows:
WUt & '(mt" mf,t)/mf,t* ! 100, (1)
WLt & '(mf,t" m0)/m0* ! 100, (2)
where mt is the mass of the specimen at time t (days), m0 is
the mass prior to immersion (t & 0) and mf,t is the final mass
of the specimen kept in the oven until constant mass after t
days of immersion in the ISS.
Bioactivity Tests
The bioactive behavior of the prepared bone-cement formu-
lations was studied over a period of 30 days. Cylindrical
specimens were immersed immediately after preparation in a
simulated body fluid (SBF: 142.0mM Na$, 5.0mM K$,
2.5mM Ca2$, 1.5mM Mg2$, 147.8mM Cl+, 4.2mM HCO3+,
1.0mM HPO42$, 0.5mM SO42+). The specimens were removed
at intervals of 76 h and 7, 14, and 30 days, rinsed with
distilled water, and dried at room temperature. One group of
specimens was then gold-coated by ion sputtering and sub-
sequently observed in a Leica Cambridge S360 scanning
electron microscope (SEM). Another group of specimens was
left uncoated for energy-dispersive spectroscopy (EDS) anal-
ysis.
The formulations presented in Table I were chosen to
determine if any of the materials used to prepare the bone
cements has inhibitory effects on the apatite formation ability
of the composites. In some of them the glass BG was replaced
by other bioactive fillers (Groups D and E), whereas in others
one or more components of the formulation were excluded
(Groups A and C). Groups F, G, and H are analogous to
groups B3, B0, and E, respectively. The only difference is the
monomer used: HEMA instead of a mixture of MMA and
AA.
The bioactive discs of SCA were immersed in SBF under
the following conditions:
1. Discs immersed alone (control discs)
2. Discs immersed together with specimen B0, after 2 days
of immersion of the bone cement
3. Discs immersed alone in the same container where spec-
imens of B0 were immersed for 2 days.
Figure 1. (a) Water uptake (WU) and (b) weight loss (WL) of the pure
and composite formulations. Solid lines, 0% BG, dashed lines,10%
BG, dotted lines, 20% and 30% BG
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The reason for these experimental conditions was to assess
the effect of components released from the bone cement on
the apatite formation ability of the referred discs. Groups 2
and 3 were chosen to compare the effect of the components
released during the first days of immersion (Group 3) with
those released during the whole immersion period (Group 2).
Statistical Analysis
One-way analysis of variance (ANOVA) was performed to
test for the significance of means for the formulations of
series B (B0, B1, B2, and B3). Whenever significant differ-
ences were found, a post-hoc test (Duncan!s multiple-range
test)21 was then applied to all possible pairs of means in order
to find which of them did not follow the null hypothesis. For
testing differences among Palacos" R and the composite
formulations, student!s t tests for independent samples were
performed.21 The normality of the data was checked by
constructing a normal probability plot of the residuals for
each studied property. The resulting distribution was a
straight line, confirming the normality assumption.
In all tests, significant differences were considered if the
p " 0.05. All tests were performed with the Statistica" 5.0
(StatSoft) software for statistical analysis.
RESULTS AND DISCUSSION
General Materials Characterization
Figure 1(a,b) shows the evolution of WU and WL for the
different formulations as a function of the immersion time in
ISS. The data show (a) the initial kinetics of water uptake for
the compositions containing glass is faster; (b) after the first
week, the behavior was the opposite, with the composites
showing a slower kinetics until an equilibrium in water up-
take is reached; (c) independently of the amount of glass
added, for long immersion times the water uptake was ap-
proximately the same for all composites (around 90% of the
value for the base matrix); (d) in general, for each given time
point, the formulations with higher WU showed lower WL,
and vice versa; (e) the approach of WL values of composition
Figure 2. SEM micrograph of a detail of the glass/polymer interface after immersion in ISS.
TABLE II. pH Evolution During Immersion in ISS
Formulation
pH at






B1 to those of formulations B2 and B3 occurred at the same
time (approximately 30 days) when the WUs of the respective
formulations were also approaching a common value.
A previous article has already shown that the most deter-
minant factor for the WU of this systems was the ratio of
MMA/AA, with the amount of starch playing only a minor
role.15 This fact can explain the behavior observed herein:
because the MMA/AA ratio was kept constant, the small
decrease in WU was due to the decreased amount of SCA
(from 60% to 30% as the BG amount was increased from 0 to
30%). The lack of a strong interaction between the polymer
and the ceramic, leading to void spaces around the glass
particles (Figure 2), could be responsible for the faster kinet-
ics of water uptake during the first days, allowing an easier
penetration of water through these voids [Figure 1(a)]; in a
second stage (from 7 to 30 days) the diffusion through the
matrix predominates (because the voids are quickly filled)
and in this case the glass is not only an inert material, but can
act as an obstacle for water diffusion. Therefore, the higher
the polymeric content, the higher the amount of water sorbed
and the faster is this sorption. These results correlate well
with the observed WL: The formulations with glass, because
of the water uptake in the poor interface, are expected to lose
mass faster and to a higher extent. This occurred because
some small glass particles could be removed from the matrix,
but mainly because of the exchange of cations between the
glass and the solution and to the loss of soluble silica in the
form of Si(OH)4 to the solution.22
This exchange of alkaline-earths from the glass with H$/
H3O$ from the solution would keep the pH at higher values,
counterbalancing the effect of AA released to the solution. As
Table II shows, there was a consistent increase in pH with the
increase of BG amount, for the studied time periods (the pH
at time t & 0 was 7.4 for all cases).
It is noteworthy that for degradation periods longer than 2
months, no difference was found in the behavior of the
composites, regardless of the content of glass added.
Regarding the mechanical properties on the dry state [24 h
after preparation, Figure 3(a,b)], the addition of more then
Figure 3. Mechanical properties of the composites: (a) yield com-
pressive stress, (b) compressive modulus. The lines correspond to the
minimum values required by the ASTM and ISO standards and to the
values obtained for Palacos# R.
Figure 4. Curing curves of selected specimens.
TABLE III. Curing Parameters
Formulation Tmax (°C) ts (min) td (s)
B0 112 # 8.5 3.8 # 0.77 19.3 # 1.5
B1 115 # 5.5 3.4 # 0.33 24.7 # 5.5
B2 114 # 9.2 3.3 # 0.38 33.3 # 5.8a
B3 116 # 2.5 3.7 # 0.54 65.0 # 7.4b
Palacos-R 107 # 2.6c 6.8 # 0.75b –
a Significant difference against B0.
b Significant differences against all the previous formulations (in the same column).
c Significant difference against B3.
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20% of the glass promoted significant improvements in the
compressive behavior, so it was possible to attain formula-
tions with properties that exceeded the requirements of the
ASTM or ISO standards. This formulation showed properties
better than one commercial bone cement (Palacos" R), which
was used here for comparison purposes: The yield stress was
approximately the same and the compressive modulus was
significantly higher. Two of the developed formulations (B0
and B2) were also subjected to tensile tests, in order to
determine the effects of the glass on these properties. As is
usual for noncoupled composites, the poor interface induces
a poor load transmission from the matrix to the filler and
limits the enhancement of tensile properties: Although the
tensile modulus increased from 1.64 # 0.048 GPa (B0) to
2.12 # 0.29 GPa (B2), the ultimate tensile strength, for the
same formulations, decreased from 40.4 # 6.5 MPa to 30.4 #
3.8 MPa.
Figure 4 shows one curing curve for each of the formu-
lations developed, as well as for Palacos" R, whereas
Table III shows the means and averages for the three
studied parameters. A one-way ANOVA performed on
formulations B0 –B3 (that is, excluding Palacos" R)
showed that significant differences were found only in td.
This seemed quite surprising, because the addition of inert
fillers (glass, TCP, HA) is usually associated with de-
creases in Tmax and increases in ts.23–25 However, in those
works the filler was always added to purely MMA-based
cements. In one case, the ratio S/L was increased from the
typical 2/1 to approximately 5/1 (due to the high amount of
glass ceramic added)23 and the decrease in Tmax is due to
the very small amount of liquid monomer in the formula-
tion. It should be also noted that the PMMA, which is the
usual solid component of conventional bone cements,
plays an active role in the polymerization of the monomer
and setting of the cement.26 The polymer is soluble in the
monomer and the MMA can diffuse into the organic matrix
of the powder, therefore leading to a matrix polymerization
of MMA in the presence of the preformed polymer. When
the filler is substituted for PMMA, this matrix polymer-
ization will be hindered and more monomer will polymer-
ize in the bulk; however, as the filler is inert (regarding the
polymerization process), it will retard the polymerization,
increasing the setting time and the time span of curing and
decreasing the Tmax, because the heat of polymerization is
released for a prolonged time.25
In the present hydrophilic bone cements, however, the
solid component is always inert; the only possible interaction
is grafting of AA onto the SCA.14 This means that the heat
released depends only on the available amount of monomer,
which will always polymerize in the bulk state. Therefore, the
Figure 5. SEM micrograph showing a calcium–phosphate layer on the surface of a specimen from
Group C, after 30 days of immersion in SBF.
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addition of glass particles is not expected to have any influ-
ence on the curing parameters of the system if the powder
amount is kept constant. Only the td was extended with higher
amounts of glass (Table III). It is hypothesized that this is due
to the lower volume fraction of the powder with increasing
filler content, due to the higher density of the glass. This
improves the wetting conditions, because the constant liquid
amount is soon exhausted, with higher volume fraction, for
wetting the particles, and the mixture reaches the dough state
earlier.
The Palacos" R results, included here for comparison, are
also shown in Table III. The Tmax was not significantly
different when compared to the hydrophilic bone cements
(except for formulation B3). However the ts was significantly
longer. These values are not in agreement with the usual
values published (approximately 70°C and 9.5 min, respec-
tively27) because a different measurement procedure was
used, as outlined in the Materials and Methods section: stor-
age of the material at 4°C, mixing at room temperature for 1
min, and measurement at 37°C. This different procedure was
performed in order to better simulate the real conditions
under which cement would be implanted. It seems that the
curing parameters should still be improved, by means of
using retarders/inhibitors, which do not negatively affect me-
chanical properties.28
Bioactivity Tests
Specimens containing 20% and 30% of bioactive glass were
prepared for immersion in SBF. Even after 30 days of im-
mersion, no signs of calcium phosphate layer formation were
found on the surface. This seemed very surprising, because
this same family of cements has previously shown a bioactive
behavior when reinforced with HA.14 In order to identify the
causes of this behavior, several formulations were prepared
specially for bioactivity tests, as explained in the Preparation
of Bone Cements section and in Table I.
Specimens of all these formulations were immersed in
SBF for up to 30 days, for SEM and EDS analysis (Materials
and Methods). Also, discs of the bioactive SCA/KMnO4
material were immersed in SBF under the conditions shown
in the Bioactivity Tests section.
From all these groups, a calcium phosphate (CaP) layer
was only observed in specimens from C (after 30 days of
immersion), F (after 7 days; at 76 h nuclei were already
observed) and H (after 7 days). CaP agglomerates were
observed on the surface of specimens from Group E (after 14
days) and on the surface of the control discs (after 7 days).
Together, these results point out that AA, whenever in solu-
tion, inhibits the formation of a CaP layer even in surface
active materials, such as the glass BG.16 As the bone cements
Figure 6. SEM micrograph showing calcium–phosphate nuclei on the surface of a specimen from
Group F, after 76 h of immersion in SBF.
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are immersed in SBF immediately after preparation (to sim-
ulate as close as possible their application in clinical situa-
tion) it is expected that they will release monomers or oli-
gomers of AA to the solution, which will then inhibit the
formation of CaP on the surface of bone cements or other
materials present in the same solution. This fact explains the
lack of any layer/agglomerate on the specimens from Groups
A and D, as well as on the discs from Groups 2 and 3.
Once a CaP layer grew on the surface of both hydrophobic
(MMA, Group C, Figure 5) and hydrophilic (HEMA, Group
F, Figure 6) formulations, the glass, the matrix, or interac-
tions between them could not be responsible for the lack of
bioactivity of the studied system. The existence of a calcium
phosphate layer on the surface of specimens from Groups F
and H, but not on those from Group G, also proves that the
bioactive behavior was due to the incorporation of glass, and
not to the use of HEMA (although tests with MMA without
glass were not performed, this is a well-known nonbioactive
material).
The composition of the coatings was assessed by EDS.
Figure 7 shows the spectra of specimens from Group H
immersed either in SBF or ISS, together with the spectrum of
Bioglass" 45S5 particles. After 7 days of immersion, the
layer on the specimen immersed in SBF contained mainly Ca
and P [Figure 7(a)]. The Si peak might be due to the silicon
present in the glass under the layer. This was corroborated by
the spectra of the specimen immersed in ISS, which shows
silicon as the main element present on the surface [Figure
7(b)], and of the glass, which shows the peak of Si as the most
intense [Figure 7(c)]. Therefore, the Ca and P appearing on
the surface of the specimen immersed in SBF should be due
to the precipitation of a calcium phosphate layer, because
these elements would be dissolved from the glass when it is
immersed in an isotonic saline solution. In this last case, only
silicon would remain on the surface, explaining the intense
peak for this element observed in Figure 7(b).
The tests performed with the bioactive discs indicated that
the inhibitory effect is due to the AA in solution, and not to
the AA present as a comonomer in the bone cement. Even the
discs immersed in SBF after removal of the bone-cement
specimen (which have been immersed for 2 days, Group 3)
did not show apatite formation, showing that the dissolved
AA is the inhibitor, and not the bone-cement device itself
(that is, not the AA incorporated in the cement).
A discordant finding was the appearance of small agglom-
erates of CaP (confirmed by EDS analysis) around Bioglass"
particles in specimens of Group E after 14 days of immersion
(which contains AA in the formulation, Figure 8). A possible
explanation for this behavior is the very high reactivity of
Bioglass",22 which induces bioactivity (after 7 days) even if
added in concentrations as low as 10 wt %.29 Here it was
present in 30 wt %, and the agglomerates were found only
after 14 days of immersion. It seems that this high reactivity
compensated for the inhibitory effect of AA.
Similar results were found by other authors. Kamitakahara
et al.30 found that AA or polyAA inhibited the formation of
apatite on the surface of AW glass ceramic even when the
concentration of polyAA was as low as 0.1 ppm. This was not
due to pH changes, because both HCl and tartaric acid al-
lowed the apatite growth. Kato et al.31 found results very
similar to the ones reported here: When in solution, polyAA
inhibited the crystallization of CaCO3, although poly (glu-
tamic acid) did not. However, when the same solution was
used in contact with a solid substrate of poly (ethylene-co-
acrylic acid) (80/20 wt/wt), rhombohedral calcite crystals
were formed, once more showing that the inhibition effect of
AA is confined to the dissolved species.
Figure 7. EDS spectra of the surface of specimens from Group H
after 7 days of immersion in SBF (a) or ISS (b). EDS spectrum of the
particles of Bioglass# 45S5 (c).
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CONCLUSIONS
Composites of bone cement containing hydrophilic and de-
gradable components could be successfully produced and
presented some advantages when compared to pure HBCs or
to commercial formulations. Some of the formulations pre-
sented mechanical properties in the range required by ASTM
and ISO standards, and even better than a typical commercial
bone cement. The addition of glass permitted the pH of the
surrounding media to be increased, which dropped because of
the initial leaching of AA. This should generate fewer ad-
verse reactions after implantation. Moreover, it led to an
increase in the dough time without significantly changing the
setting time or maximum polymerization temperature.
Compositions containing AA did not show bioactivity
unless a very reactive glass was employed, showing that a
coupled influence of low-reactivity glass and inhibitor sub-
stance was responsible for the lack of bioactivity. The inhib-
itor substance was determined to be the AA leached out from
the specimens due to incomplete polymerization, because
formulations containing only MMA or HEMA were bioactive
when filled with either glass. Therefore, in order to obtain
highly bioactive bone cements, HEMA should be used as the
hydrophilic substance and more reactive glasses as the bio-
active component. These may even allow apatite formation
inside the pores generated during degradation of the degrad-
able component, creating a strong adhesion to bone once the
cement is implanted.
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